cefdinir

North America

Canada (0)
No result.
United States (20)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 125MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 250MG/5ML FOR SUSPENSION
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
CEFDINIR 300MG caps
Y
Rx
oral
J01DD15
OMNICEF caps
N
oral
J01DD15
OMNICEF FOR SUSPENSION
N
N

oral
J01DD15
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CEFDINIR 125MG/5ML FOR SUSPENSION
210534/1
ANDA
19-02-2021
CEFDINIR 125MG/5ML FOR SUSPENSION
65473/1
ANDA
14-12-2007
CEFDINIR 125MG/5ML FOR SUSPENSION
65259/1
ANDA
31-05-2006
CEFDINIR 125MG/5ML FOR SUSPENSION
65429/1
ANDA
18-07-2007
CEFDINIR 125MG/5ML FOR SUSPENSION
65337/1
ANDA
06-04-2007
CEFDINIR 125MG/5ML FOR SUSPENSION
65332/1
ANDA
04-05-2007
CEFDINIR 250MG/5ML FOR SUSPENSION
210534/2
ANDA
19-02-2021
CEFDINIR 250MG/5ML FOR SUSPENSION
65473/2
ANDA
14-12-2007
CEFDINIR 250MG/5ML FOR SUSPENSION
65259/2
ANDA
07-05-2007
CEFDINIR 250MG/5ML FOR SUSPENSION
65429/2
ANDA
18-07-2007
CEFDINIR 250MG/5ML FOR SUSPENSION
65337/2
ANDA
06-04-2007
CEFDINIR 250MG/5ML FOR SUSPENSION
65332/2
ANDA
04-05-2007
CEFDINIR 300MG caps
210220/1
ANDA
19-02-2021
CEFDINIR 300MG caps
65434/1
ANDA
07-01-2008
CEFDINIR 300MG caps
65264/1
ANDA
19-05-2006
CEFDINIR 300MG caps
65418/1
ANDA
18-07-2007
CEFDINIR 300MG caps
65330/1
ANDA
06-04-2007
CEFDINIR 300MG caps
65368/1
ANDA
09-05-2007
OMNICEF caps
50739/1
NDA
04-12-1997
OMNICEF FOR SUSPENSION
50749/2
50749/1
NDA
NDA
29-07-2004
04-12-1997
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
OMNICEF 25 MG/ML powd for oral susp
Rx
-
J01DD15
OMNICEF 300 MG caps, hard
Rx
-
J01DD15
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
OMNICEF 25 MG/ML powd for oral susp
Nationell decentral eller ömsesidig
19-12-1997
30-06-2006
OMNICEF 300 MG caps, hard
Nationell decentral eller ömsesidig
19-12-1997
30-06-2006
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (0)
No result.